OTCMKTS:LNDZF Evome Medical Technologies (LNDZF) Stock Price, News & Analysis $0.10 0.00 (0.00%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$0.10▼$0.1050-Day Range$0.01▼$0.2052-Week Range$0.01▼$0.21VolumeN/AAverage Volume8,914 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest Get Evome Medical Technologies alerts: Email Address Ad True Gold RepublicChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a population of over 1.4 BILLION is “buying gold like there’s no tomorrow,” according to The New York Times. China, a rising global economic threat, aims to reduce its dependence on the US dollar… . Click here now to get your free 'De-Dollarization' Guide. About Evome Medical Technologies Stock (OTCMKTS:LNDZF)Evome Medical Technologies Inc., through its subsidiaries, engages in the development, production, and sale of medical devices and products in the United States. The company's medical devices are used for pain management and physical therapy treatments, including cold/hot therapy products, neuromuscular electrical stimulation devices, transcutaneous electrical nerve stimulation devices, and ultrasound treatment devices. It also offers wearable technology and products that are used to enhance physical stability. The company was formerly known as Salona Global Medical Device Corporation and changed its name to Evome Medical Technologies Inc. in January 2024. Evome Medical Technologies Inc. is headquartered in Shirley, New York.Read More LNDZF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart LNDZF Stock News HeadlinesAugust 15, 2024 | globenewswire.comEvome Medical Technologies Reviews Highlights of Low-CapEx Revenue Growth PlanAugust 12, 2024 | globenewswire.comEvome Medical Technologies Reports Second Quarter 2024 Financial ResultsSeptember 7, 2024 | Deal Maker (Ad)The solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.July 3, 2024 | globenewswire.comEvome Medical Technologies Retains irlabs for Investor Relations ServicesJune 3, 2024 | globenewswire.comEvome Medical Technologies Announces Update Call with CEO Mike Seckler for Tuesday, June 4, 2024; Provides Update on Strong Q2May 30, 2024 | globenewswire.comEvome Medical Technologies Announces Biodex Generated 100% Sales Growth Comparing April 2024 to January 2024, Plans to Shed Remaining Non-Core Units to Pay Off Remaining Acquisition DebtApril 12, 2024 | finance.yahoo.comEvome Strengthens Major Creditor Relationship After the Sale of the Simbex Unit to Riddell, LOI Related to Simbex Acquisition Debt is CancelledApril 2, 2024 | finance.yahoo.comCanadian Investment Regulatory Organization Trade Resumption - EVMTSeptember 7, 2024 | Deal Maker (Ad)The solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.April 2, 2024 | finance.yahoo.comEvome Sells Simbex R&D Business Unit to Riddell for $4.83M in Cash; Improves Balance Sheet, Reduces Biodex Acquisition DebtApril 1, 2024 | globenewswire.comEvome Medical Technologies Punctuates Turn Around Plan with Strong Fourth Quarter Resulting in Positive Annual Adjusted EBITDA for Fiscal Year 2023February 27, 2024 | globenewswire.comEvome Medical Engages ICP Securities Inc. for Automated Market Making ServicesFebruary 15, 2024 | finance.yahoo.comEvome Medical Technologies Bolsters Board of Directors with Appointment of Strategic Senior Healthcare Executives Wayne Anderson and Bill Garbarini, Appoints Kenneth Kashkin, MD, as ChairmanFebruary 15, 2024 | globenewswire.comEvome Medical Technologies Bolsters Board of Directors with Appointment of Strategic Senior Healthcare Executives Wayne Anderson and Bill Garbarini, Appoints Kenneth Kashkin, MD, as ChairmanFebruary 8, 2024 | finance.yahoo.comEvome Medical Technologies Executes Non-Binding Letter of Intent to Extend Remaining Simbex Acquisition Debt to June 2025; Increases Sales Targets by 7.5% for Biodex Distribution Contracts; Raises Biodex Product Pricing by 2% for 2024January 31, 2024 | finance.yahoo.comEvome Medical Technologies Reduces Acquisition Debt, Bolsters Management Team to Support SpaceTeck Knee™ and Reactive Step Trainer 2024 Product Roll-OutJanuary 18, 2024 | finance.yahoo.comSalona Global Finalizes Name Change to Evome Medical Technologies to Reflect Turn Around and New Innovation Focus; Restructures Board of DirectorsJanuary 11, 2024 | finance.yahoo.comSalona Global Announces Exclusive Partnership with Recently Launched U.S. Military Veteran (VA) Focused Distribution CompanySee More Headlines Receive LNDZF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Evome Medical Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Devices Sub-IndustryMedical Equipment Current SymbolOTCMKTS:LNDZF CUSIPN/A CIK1617765 Webwww.inspirafin.ca Phone(800) 760-6826FaxN/AEmployees100Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesJeffrey ChuExecutive OfficerMr. Michael Seckler (Age 50)CEO & Executive Director Ms. Cherine Pottinger-Harris (Age 43)Principal Accounting Officer & Interim Chief Financial Officer Mr. Joseph G. Martinez Esq. (Age 66)Senior VP of Legal & Compliance, General Counsel and Secretary Mr. Jethro Rothe-KushelVice President of Capital Markets & Financial CommunicationsKey CompetitorsAllyMe GroupOTCMKTS:WWINAlpha Tau MedicalNASDAQ:DRTSWAltair InternationalOTCMKTS:ATAOAmerican Medical TechnologiesOTCMKTS:ADLIAnzu Special Acquisition Corp INASDAQ:ANZUWView All Competitors LNDZF Stock Analysis - Frequently Asked Questions How have LNDZF shares performed this year? Evome Medical Technologies' stock was trading at $0.1516 at the start of the year. Since then, LNDZF stock has decreased by 34.0% and is now trading at $0.10. View the best growth stocks for 2024 here. How do I buy shares of Evome Medical Technologies? Shares of LNDZF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:LNDZF) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evome Medical Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evome Medical Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.